Fiscal Year End Company Status Exempt Flag July 31 Trading N Board of Directors Name Position Bernard R. Patriacca  Director of the Board Danilo Netto  Director of the Board Paul Baehr  Chairperson of the Board   Director of the Board   President/CEO & Interim Director of Finance Robert DeLuccia  Director of the Board Robert Heft  Director of the Board Thomas O. Hecht  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 10/Apr/1972    Canada      Exchange Filing Office Location Montreal Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Biotechnology/Biopharmaceutical  (not available)  Securities Symbol Security Name Market Status IBT IBEX Technologies Inc TSX Venture TRADING Name History From To IBEX Technologies Inc. 19/Dec/2007 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR Not Received Associations Auditing Firm:  PricewaterhouseCoopers LLP Law Firm:  Heenan Blaikie Subsidiary:  IBEX Pharmaceuticals Inc. Transfer Agent:  CIBC Mellon Trust Company
Latest Information Type Date Title News Releases  22/Mar/2013  NEWS RELEASE - IBEX ANNOUNCES DEPARTURE OF ITS DIRECTOR OF FINANCE[MARKETWIRE]     NEWS RELEASE - DEPARTURE OF DIRECTOR OF FINANCE[MARKET NEWS]     NEWS RELEASE - IBEX REPORTS RESULTS FOR THE SECOND QUARTER AND THE SIX MONTHS ENDED JANUARY 31 2013[MARKETWIRE] Bulletins  22/Jan/2013  Property-Asset or Share Purchase Agreement Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data